Literature DB >> 10882143

HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF.

O D Lau1, T K Kundu, R E Soccio, S Ait-Si-Ali, E M Khalil, A Vassilev, A P Wolffe, Y Nakatani, R G Roeder, P A Cole.   

Abstract

Histone acetyltransferases (HATs) play important roles in the regulation of gene expression. In this report, we describe the design, synthesis, and application of peptide CoA conjugates as selective HAT inhibitors for the transcriptional coactivators p300 and PCAF. Two inhibitors (Lys-CoA for p300 and H3-CoA-20 for PCAF) were found to be potent (IC(50) approximately = 0.5 microM) and selective (approximately 200-fold) in blocking p300 and PCAF HAT activities. These inhibitors were used to probe enzymatic and transcriptional features of HAT function in several assay systems. These compounds should be broadly useful as biological tools for evaluating the roles of HATs in transcriptional studies and may serve as lead agents for the development of novel antineoplastic therapeutics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882143     DOI: 10.1016/s1097-2765(00)80452-9

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  123 in total

1.  Targeting of histone acetyltransferase p300 by cyclopentenone prostaglandin Δ(12)-PGJ(2) through covalent binding to Cys(1438).

Authors:  Kodihalli C Ravindra; Vivek Narayan; Gerald H Lushington; Blake R Peterson; K Sandeep Prabhu
Journal:  Chem Res Toxicol       Date:  2011-12-16       Impact factor: 3.739

2.  Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.

Authors:  Erin M Bowers; Gai Yan; Chandrani Mukherjee; Andrew Orry; Ling Wang; Marc A Holbert; Nicholas T Crump; Catherine A Hazzalin; Glen Liszczak; Hua Yuan; Cecilia Larocca; S Adrian Saldanha; Ruben Abagyan; Yan Sun; David J Meyers; Ronen Marmorstein; Louis C Mahadevan; Rhoda M Alani; Philip A Cole
Journal:  Chem Biol       Date:  2010-05-28

3.  Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex.

Authors:  Christy J Fryer; Elise Lamar; Ivana Turbachova; Chris Kintner; Katherine A Jones
Journal:  Genes Dev       Date:  2002-06-01       Impact factor: 11.361

4.  A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription.

Authors:  Zhi-Qing Huang; Jiwen Li; Laurent M Sachs; Philip A Cole; Jiemin Wong
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

5.  In vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation.

Authors:  F Jeffrey Dilworth; Karen J Seaver; Anna L Fishburn; Steve L Htet; Stephen J Tapscott
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

Review 6.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

Review 7.  Chemical biology of histone acetyltransferase natural compounds modulators.

Authors:  Fabrizio Dal Piaz; Antonio Vassallo; Osmany Cuesta Rubio; Sabrina Castellano; Gianluca Sbardella; Nunziatina De Tommasi
Journal:  Mol Divers       Date:  2011-01-01       Impact factor: 2.943

8.  Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.

Authors:  Kanagaraj Subramanian; Darren M Hutt; Samantha M Scott; Vijay Gupta; Shu Mao; William E Balch
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

Review 9.  Toward transcriptional therapies for the failing heart: chemical screens to modulate genes.

Authors:  Timothy A McKinsey; Eric N Olson
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

10.  Inhibition of histone acetyltransferase by glycosaminoglycans.

Authors:  Jo Ann Buczek-Thomas; Edward Hsia; Celeste B Rich; Judith A Foster; Matthew A Nugent
Journal:  J Cell Biochem       Date:  2008-09-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.